1z7g

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1z7g" size="450" color="white" frame="true" align="right" spinBox="true" caption="1z7g, resolution 1.90&Aring;" /> '''Free human HGPRT'''...)
Line 1: Line 1:
-
[[Image:1z7g.gif|left|200px]]<br />
+
[[Image:1z7g.gif|left|200px]]<br /><applet load="1z7g" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1z7g" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1z7g, resolution 1.90&Aring;" />
caption="1z7g, resolution 1.90&Aring;" />
'''Free human HGPRT'''<br />
'''Free human HGPRT'''<br />
==Overview==
==Overview==
-
Human hypoxanthine-guanine phosphoribosyltransferase (HGPRT) catalyses the, synthesis of the purine nucleoside monophosphates, IMP and GMP, by the, addition of a 6-oxopurine base, either hypoxanthine or guanine, to the, 1-beta-position of 5-phospho-alpha-d-ribosyl-1-pyrophosphate (PRib-PP)., The mechanism is sequential, with PRib-PP binding to the free enzyme prior, to the base. After the covalent reaction, pyrophosphate is released, followed by the nucleoside monophosphate. A number of snapshots of the, structure of this enzyme along the reaction pathway have been captured., These include the structure in the presence of the inactive purine base, analogue, 7-hydroxy [4,3-d] pyrazolo pyrimidine (HPP) and PRib-PP.Mg2+, and in complex with IMP or GMP. The third structure is that of the, immucillinHP.Mg(2+).PP(i) complex, a transition-state analogue. Here, the, first crystal structure of free human HGPRT is reported to 1.9A, resolution, showing that significant conformational changes have to occur, for the substrate(s) to bind and for catalysis to proceed. Included in, these changes are relative movement of subunits within the tetramer, rotation and extension of an active-site alpha-helix (D137-D153), reorientation of key active-site residues K68, D137 and K165, and the, rearrangement of three active-site loops (100-128, 165-173 and 186-196)., Toxoplasma gondii HGXPRT is the only other 6-oxopurine, phosphoribosyltransferase structure solved in the absence of ligands., Comparison of this structure with human HGPRT reveals significant, differences in the two active sites, including the structure of the, flexible loop containing K68 (human) or K79 (T.gondii).
+
Human hypoxanthine-guanine phosphoribosyltransferase (HGPRT) catalyses the synthesis of the purine nucleoside monophosphates, IMP and GMP, by the addition of a 6-oxopurine base, either hypoxanthine or guanine, to the 1-beta-position of 5-phospho-alpha-d-ribosyl-1-pyrophosphate (PRib-PP). The mechanism is sequential, with PRib-PP binding to the free enzyme prior to the base. After the covalent reaction, pyrophosphate is released followed by the nucleoside monophosphate. A number of snapshots of the structure of this enzyme along the reaction pathway have been captured. These include the structure in the presence of the inactive purine base analogue, 7-hydroxy [4,3-d] pyrazolo pyrimidine (HPP) and PRib-PP.Mg2+, and in complex with IMP or GMP. The third structure is that of the immucillinHP.Mg(2+).PP(i) complex, a transition-state analogue. Here, the first crystal structure of free human HGPRT is reported to 1.9A resolution, showing that significant conformational changes have to occur for the substrate(s) to bind and for catalysis to proceed. Included in these changes are relative movement of subunits within the tetramer, rotation and extension of an active-site alpha-helix (D137-D153), reorientation of key active-site residues K68, D137 and K165, and the rearrangement of three active-site loops (100-128, 165-173 and 186-196). Toxoplasma gondii HGXPRT is the only other 6-oxopurine phosphoribosyltransferase structure solved in the absence of ligands. Comparison of this structure with human HGPRT reveals significant differences in the two active sites, including the structure of the flexible loop containing K68 (human) or K79 (T.gondii).
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1Z7G is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Hypoxanthine_phosphoribosyltransferase Hypoxanthine phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.8 2.4.2.8] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1Z7G OCA].
+
1Z7G is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Hypoxanthine_phosphoribosyltransferase Hypoxanthine phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.8 2.4.2.8] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Z7G OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Hypoxanthine phosphoribosyltransferase]]
[[Category: Hypoxanthine phosphoribosyltransferase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Brereton, I.M.]]
+
[[Category: Brereton, I M.]]
-
[[Category: Guddat, L.W.]]
+
[[Category: Guddat, L W.]]
-
[[Category: Jersey, J.de.]]
+
[[Category: Jersey, J de.]]
-
[[Category: Keough, D.T.]]
+
[[Category: Keough, D T.]]
[[Category: flexibility]]
[[Category: flexibility]]
[[Category: nucleotide binding]]
[[Category: nucleotide binding]]
[[Category: trans cis peptide bond isomerization]]
[[Category: trans cis peptide bond isomerization]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:30:34 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:12:48 2008''

Revision as of 14:12, 21 February 2008


1z7g, resolution 1.90Å

Drag the structure with the mouse to rotate

Free human HGPRT

Contents

Overview

Human hypoxanthine-guanine phosphoribosyltransferase (HGPRT) catalyses the synthesis of the purine nucleoside monophosphates, IMP and GMP, by the addition of a 6-oxopurine base, either hypoxanthine or guanine, to the 1-beta-position of 5-phospho-alpha-d-ribosyl-1-pyrophosphate (PRib-PP). The mechanism is sequential, with PRib-PP binding to the free enzyme prior to the base. After the covalent reaction, pyrophosphate is released followed by the nucleoside monophosphate. A number of snapshots of the structure of this enzyme along the reaction pathway have been captured. These include the structure in the presence of the inactive purine base analogue, 7-hydroxy [4,3-d] pyrazolo pyrimidine (HPP) and PRib-PP.Mg2+, and in complex with IMP or GMP. The third structure is that of the immucillinHP.Mg(2+).PP(i) complex, a transition-state analogue. Here, the first crystal structure of free human HGPRT is reported to 1.9A resolution, showing that significant conformational changes have to occur for the substrate(s) to bind and for catalysis to proceed. Included in these changes are relative movement of subunits within the tetramer, rotation and extension of an active-site alpha-helix (D137-D153), reorientation of key active-site residues K68, D137 and K165, and the rearrangement of three active-site loops (100-128, 165-173 and 186-196). Toxoplasma gondii HGXPRT is the only other 6-oxopurine phosphoribosyltransferase structure solved in the absence of ligands. Comparison of this structure with human HGPRT reveals significant differences in the two active sites, including the structure of the flexible loop containing K68 (human) or K79 (T.gondii).

Disease

Known diseases associated with this structure: HPRT-related gout OMIM:[308000], Lesch-Nyhan syndrome, 300322, OMIM:[308000]

About this Structure

1Z7G is a Single protein structure of sequence from Homo sapiens. Active as Hypoxanthine phosphoribosyltransferase, with EC number 2.4.2.8 Full crystallographic information is available from OCA.

Reference

The crystal structure of free human hypoxanthine-guanine phosphoribosyltransferase reveals extensive conformational plasticity throughout the catalytic cycle., Keough DT, Brereton IM, de Jersey J, Guddat LW, J Mol Biol. 2005 Aug 5;351(1):170-81. PMID:15990111

Page seeded by OCA on Thu Feb 21 16:12:48 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools